{"id":"F2015L00463","name":"Australia New Zealand Food Standards Code – Schedule 29 – Special purpose foods","slug":"australia-new-zealand-food-standards-code-schedule-29-special-purpose-foods","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":93081,"registerId":"commonwealth-F2015L00463-current","compilationNumber":null,"startDate":"2026-04-02","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Australia New Zealand Food Standards Code – Schedule 29 – Special purpose foods","content":"Schedule 29 Special purpose foods\n\nNote 1 This instrument is a standard under the Food Standards Australia New Zealand Act 1991 (Cth). The standards together make up the Australia New Zealand Food Standards Code. See also section 1.1.1—3.\n\nSpecial purpose foods are regulated by Part 9 of Chapter 2, which contains Standard 2.9.1, Standard 2.9.2, Standard 2.9.3, Standard 2.9.4, Standard 2.9.5 and Standard 2.9.6. This Standard prescribes information for these standards.\n\nNote 2 The provisions of the Code that apply in New Zealand are incorporated in, or adopted under, the Food Act 2014 (NZ). See also section 1.1.1—3.\n\nS29—1 Name\n\nThis Standard is Australia New Zealand Food Standards Code – Schedule 29 – Special purpose foods.\n\nNote Commencement: \nThis Standard commences on 1 March 2016, being the date specified as the commencement date in notices in the Gazette and the New Zealand Gazette under section 92 of the Food Standards Australia New Zealand Act 1991 (Cth). See also section 93 of that Act.\n\nS29—2 Infant formula products—calculation of energy content\n\n(1) For paragraph 2.9.1—4(2)(a), the energy content of infant formula product must be calculated using:\n\n(a) the energy contributions of the following \\*components only:\n\n(i) fat; and\n\n(ii) protein; and\n\n(iii) carbohydrate; and\n\n(b) the relevant energy factors set out in section S11—2.\n\n(2) The energy content of an infant formula product must be expressed in kilojoules.\n\nS29—2A Infant formula products—calculation of protein content\n\nFor paragraph 2.9.1—4(2)(b), the protein content of infant formula product must be calculated by multiplying the nitrogen content of the product by a nitrogen‑to‑protein conversion factor of 6.25.\n\nS29—2B Infant formula products—calculation of vitamin A content\n\nFor paragraph 2.9.1—4(2)(c), the vitamin A content of infant formula products must be calculated using only the retinol forms of vitamin A prescribed in Column 1 of Table S29—23.\n\nS29—3 Infant formula products—L-amino acids that must be present\n\nFor subsection 2.9.1—6(5) and section 2.9.1—33, the table is:\n\nL-amino acids that must be present in infant formula products\n\n| L-amino acid | Minimum amount per 100 kJ |\n| ------------- | ------------------------- |\n| Cysteine | 9 mg |\n| Histidine | 10 mg |\n| Isoleucine | 22 mg |\n| Leucine | 40 mg |\n| Lysine | 27 mg |\n| Methionine | 6 mg |\n| Phenylalanine | 19 mg |\n| Threonine | 18 mg |\n| Tryptophan | 8 mg |\n| Tyrosine | 18 mg |\n| Valine | 22 mg |\n\nS29—4 Infant formula products—limits on fatty acids\n\nFor paragraphs 2.9.1—7(1)(g) and 2.9.1—34(1)(g), the table is:\n\nLimits on fatty acids that may be present in infant formula products\n\n| Column 1 | Column 2 | |\n| ----------------------- | ----------------------------------------- | --- |\n| Substance | Maximum amountper 100 kJ | |\n| Docosahexaenoic acid | 12 mg | |\n| Total trans fatty acids | Not more than 4% of the total fatty acids | |\n| Erucic acid (22:1) | Not more than 1% of the total fatty acids | |\n\nS29—5 Vitamins, minerals, electrolytes and other substances required in infant formula and special medical purpose product for infants\n\nFor sections 2.9.1—7(2)(b)(i), 2.9.1—8(1), 2.9.1—34(2)(b) and 2.9.1—36(1), the table is:\n\nVitamins, minerals, electrolytes and other nutritive substances required in infant formula and special medical purpose product for infants\n\n```html\n

Column 1

Column 2

Column 3

Column 4

Substance

Minimum amount
per 100 kJ

Maximum amount
per 100 kJ

Guidance upper level
per 100 kJ (see Note)

Vitamins

Vitamin A

14 μg RE

43 μg RE

Vitamin D

0.24 μg

0.63 μg

Vitamin C

1.7 mg

17 mg

Thiamin

10 μg

72 µg

Riboflavin

14.3 μg

120 µg

Niacin

72 μg

359 µg

Vitamin B6

8 μg

42 µg

Folic acid

2.4 μg

12 µg

Pantothenic acid

96 μg

478 µg

Vitamin B12

0.02 μg

0.36 µg

Biotin

0.24 μg

2.4 µg

Vitamin E

0.14 mg α-TE

1.2 mg α-TE

Vitamin K

0.24 μg

6 µg

Minerals

Calcium

12 mg

35 mg

Phosphorus

6 mg

24 mg

Magnesium

1.2 mg

3.6 mg

Iron

0.14 mg

0.48 mg

Iodine

2.4 μg

14 µg

Copper

8 μg

29 µg

Zinc

0.12 mg

0.36 mg

Manganese

0.24 μg

24 μg

Selenium

0.48 μg

2.2 µg

Electrolytes

Chloride

12 mg

38 mg

Sodium

4.8 mg

14 mg

Potassium

14 mg

43 mg

Other essential substances

Choline

1.7 mg

12 mg

L-carnitine

0.3 mg

0.8 mg

Inositol

1 mg

10 mg

\n```\n\nNote It is recommended that infant formula and a special medical purpose product for infants contain a substance listed in Column 1 of the table in an amount that is not more than the amount (if any) specified for that substance in Column 4 of the table. The amounts specified in Column 4 are Guidance Upper Levels and are recommended upper levels for nutrients which pose no significant risks on the basis of current scientific knowledge. These levels are values derived on the basis of meeting nutritional requirements of infants and an established history of apparent safe use. These Guidance Upper Levels should not be exceeded unless higher nutrient levels cannot be avoided due to high or variable contents in constituents of infant formulas or special medical purpose product for infants; or due to technological reasons.\n\nS29—6 Vitamins, minerals and electrolytes required in follow-on formula\n\nFor subparagraph 2.9.1—7(2)(b)(ii) and subsection 2.9.1—8(2), the table is:\n\nVitamins, minerals and electrolytes required in follow-on formula\n\n| Column 1 | Column 2 | Column 3 | Column 4 |\n| ------------------------------- | ------------------------ | ------------------------ | ----------------------------------------- |\n| Vitamin, mineral or electrolyte | Minimum amountper 100 kJ | Maximum amountper 100 kJ | Guidance upper levelper 100 kJ (see Note) |\n| Vitamins | | | |\n| Vitamin A | 14 μg RE | 43 μg RE | |\n| Vitamin D | 0.24 μg | 0.72 μg | |\n| Vitamin C | 1.7 mg | | 17 mg |\n| Thiamin | 10 μg | | 72 µg |\n| Riboflavin | 14.3 μg | | 120 µg |\n| Niacin | 72 μg | | 359 µg |\n| Vitamin B6 | 8 μg | | 42 µg |\n| Folic acid | 2.4 μg | | 12 µg |\n| Pantothenic acid | 96 μg | | 478 µg |\n| Vitamin B12 | 0.02 μg | | 0.36 µg |\n| Biotin | 0.24 μg | | 2.4 µg |\n| Vitamin E | 0.14 mg α-TE | | 1.2 mg α-TE |\n| Vitamin K | 0.24 μg | | 6 µg |\n| Minerals | | | |\n| Calcium | 12 mg | | 43 mg |\n| Phosphorus | 6 mg | | 24 mg |\n| Magnesium | 1.2 mg | | 3.6 mg |\n| Iron | 0.24 mg | 0.48 mg | |\n| Iodine | 2.4 μg | | 14 µg |\n| Copper | 8 μg | | 29 µg |\n| Zinc | 0.12 mg | | 0.36 mg |\n| Manganese | 0.24 μg | | 24 μg |\n| Selenium | 0.48 μg | | 2.2 µg |\n| Electrolytes | | | |\n| Chloride | 12 mg | 38 mg | |\n| Sodium | 4.8 mg | 14 mg | |\n| Potassium | 14 mg | 43 mg | |\n\nNote It is recommended that follow-on formula contain a substance listed in Column 1 of the table in an amount that is not more than the amount (if any) specified for that substance in column 4 of the table. The amounts specified are Guidance Upper Levels and are recommended upper levels for nutrients which pose no significant risks on the basis of current scientific knowledge. These levels are values derived on the basis of meeting nutritional requirements of infants and an established history of apparent safe use. The Guidance Upper Levels should not be exceeded unless higher nutrient levels cannot be avoided due to high or variable contents in constituents of follow-on formula or due to technological reasons.\n\nS29—7 Optional nutritive substances in infant formula and special medical purpose product for infants\n\nFor subsection 2.9.1—9(1) and section 2.9.1—37, the table is set out below.\n\nOptional nutritive substances in infant formula and special medical purpose product for infants\n\n| Column 1 | Column 2 | Column 3 |\n| ------------------------------------------------------------------------------------------------------------------------------------ | ------------------------- | --------------------------------------------------------------- |\n| Substance | Minimum amount per 100 kJ | Maximum amount per 100 kJ |\n| 2′-fucosyllactose permitted for use by Standard 1.5.2 | | 96 mg |\n| 3-fucosyllactose permitted for use by Standard 1.5.2 | | 80 mg |\n| 3′-sialyllactose sodium salt permitted for use by Standard 1.5.2 | | 8 mg |\n| 6′-sialyllactose sodium salt permitted for use by Standard 1.5.2 | | 16 mg |\n| A combination of 2′-fucosyllactose and difucosyllactose, permitted for use by Standard 1.5.2 | | 96 mg |\n| A combination of: 2′-fucosyllactose permitted for use by Standard 1.5.2; and lacto-N-neotetraose permitted for use by Standard 1.5.2 | | 96 mg which contains not more than 24 mg of lacto-N-neotetraose |\n| Adenosine-5′-monophosphate | | 0.36 mg |\n| Cytidine-5′-monophosphate | | 0.6 mg |\n| Guanosine-5′monophosphate | | 0.4 mg |\n| Inosine-5′-monophosphate | | 0.24 mg |\n| Lactoferrinlacto-N-tetraose permitted for use by Standard 1.5.2 | | 40 mg32 mg |\n| Lutein | 1.5 µg | 5 µg |\n| Milk fat globule membrane-enriched whey protein concentrate | 0.14 g | 0.28 g |\n| Taurine | | 2.9 mg |\n| Uridine-5′-monophosphate | | 0.42 mg |\n\nS29—8 Optional nutritive substances in follow-on formula\n\nFor subsection 2.9.1—9(2), the table is set out below.\n\nOptional nutritive substances in follow-on formula\n\n| Column 1 | Column 2 | Column 3 | Column 4 |\n| ------------------------------------------------------------------------------------------------------------------------------------ | ------------------------- | --------------------------------------------------------------- | ------------------------------------------ |\n| Substance | Minimum amount per 100 kJ | Maximum amount per 100 kJ | Guidance upper level per 100 kJ (see Note) |\n| 2′-fucosyllactose permitted for use by Standard 1.5.2 | | 96 mg | |\n| 3-fucosyllactose permitted for use by Standard 1.5.2 | | 80 mg | |\n| 3′-sialyllactose sodium salt permitted for use by Standard 1.5.2 | | 8 mg | |\n| 6′-sialyllactose sodium salt permitted for use by Standard 1.5.2 | | 16 mg | |\n| A combination of 2′-fucosyllactose and difucosyllactose, permitted for use by Standard 1.5.2 | | 96 mg | |\n| A combination of: 2′-fucosyllactose permitted for use by Standard 1.5.2; and lacto-N-neotetraose permitted for use by Standard 1.5.2 | | 96 mg which contains not more than 24 mg of lacto-N-neotetraose | |\n| Adenosine-5′-monophosphate | | 0.36 mg | |\n| L-carnitine | 0.3 mg | | |\n| Choline | | | 12 mg |\n| Cytidine-5′-monophosphate | | 0.6 mg | |\n| Guanosine-5′-monophosphate | | 0.4 mg | |\n| Inosine-5′-monophosphate | | 0.24 mg | |\n| Lactoferrin | | 40 mg | |\n| lacto-N-tetraose permitted for use by Standard 1.5.2 | | 32 mg | |\n| Lutein | 1.5 µg | 5 µg | |\n| Milk fat globule membrane-enriched whey protein concentrate | 0.14 g | 0.28 g | |\n| Inositol | | | 10 mg |\n| Taurine | | 2.9 mg | |\n| Uridine-5′-monophosphate | | 0.42 mg | |\n\nNote It is recommended that follow-on formula contain a substance listed in Column 1 of the table in an amount that is not more than the amount (if any) specified for that substance in Column 4 of the table. The amounts specified in Column 4 are Guidance Upper Levels and are recommended upper levels for nutrients which pose no significant risks on the basis of current scientific knowledge. These levels are values derived on the basis of meeting nutritional requirements of infants and an established history of apparent safe use. The Guidance Upper Levels should not be exceeded unless higher nutrient levels cannot be avoided due to high or variable contents in constituents of follow-on formula or due to technological reasons.\n\nS29—9 Permitted forms of nutritive substances in infant formula products\n\nFor paragraphs 2.9.1—10(b) and 2.9.1—38(b), the table is set out below.\n\nPermitted forms for nutritive substances used in infant formula products\n\n| Substance | Permitted forms |\n| ------------------------------------------------------------------------------------------------------------------------------------ | ------------------------------------------------------------------ |\n| 2′-fucosyllactose permitted for use by Standard 1.5.2 | 2′-fucosyllactose |\n| 3-fucosyllactose permitted for use by Standard 1.5.2 | 3-fucosyllactose |\n| 3′-sialyllactose sodium salt permitted for use by Standard 1.5.2 | 3′-sialyllactose sodium salt |\n| 6'-sialyllactose sodium salt permitted for use by Standard 1.5.2 | 6'-sialyllactose sodium salt |\n| A combination of 2′-fucosyllactose and difucosyllactose, permitted for use by Standard 1.5.2 | 2'-fucosyllactose and difucosyllactose |\n| A combination of: 2′-fucosyllactose permitted for use by Standard 1.5.2; and lacto-N-neotetraose permitted for use by Standard 1.5.2 | 2′-fucosyllactose and lacto-N-neotetraose |\n| Adenosine-5′-monophosphate | Adenosine-5′- monophosphate |\n| L-carnitine | L-carnitine |\n| | L-carnitine hydrochloride |\n| | L-carnitine tartrate |\n| Choline | Choline chloride |\n| | Choline bitartrate |\n| | Choline |\n| | Choline citrate |\n| | Choline hydrogen tartrate |\n| Cytidine-5′-monophosphate | Cytidine-5′-monophosphate |\n| Guanosine-5′-monophosphate | Guanosine-5′-monophosphate |\n| | Guanosine-5′-monophosphate sodium salt |\n| Inosine-5′-monophosphate | Inosine-5′-monophosphate |\n| | Inosine-5′-monophosphate sodium salt |\n| Lactoferrin | Bovine lactoferrin |\n| lacto-N-tetraose permitted for use by Standard 1.5.2 | lacto-N-tetraose |\n| Lutein | Lutein from Tagetes erecta L. |\n| Milk fat globule membrane-enriched whey protein concentrate | Bovine milk fat globule membrane-enriched whey protein concentrate |\n| Inositol | Myo-inositol |\n| Taurine | Taurine |\n| Uridine-5′-monophosphate | Uridine-5′-monophosphate sodium salt |\n\nNote Section S29—23 lists the permitted forms of vitamins, minerals and electrolytes in infant formula products.\n\nS29—9A Infant formula products—conditions on use of permitted nutritive substances\n\nThe table for this section is as follows:\n\nConditions of use for permitted nutritive substances\n\n| Column 1 | Column 2 | Column 3 |\n| ----------------------------------------------------------- | ------------------------------------------------------------------ | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Substance | Permitted Form | Conditions of use |\n| Lactoferrin | Bovine lactoferrin | During the exclusive use period, may only be sold under the brand Synlait for *use as a nutritive substance in an infant formula product.For the purposes of condition 1 above, exclusive use period means the period commencing on the date of gazettal of the Food Standards (Application A1253 – Bovine Lactoferrin in Infant Formula Products) Variation and ending 15 months after that date. |\n| Milk fat globule membrane-enriched whey protein concentrate | Bovine milk fat globule membrane-enriched whey protein concentrate | 1. During the exclusive use period, may only be sold under the brand Lacprodan® MFGM-10 for *use as a nutritive substance in an infant formula product.2. For the purposes of condition 1 above, exclusive use period means the period commencing on the date of gazettal of the Food Standards (Application A1307 – Milk fat globule membrane as a nutritive substance in infant formula products) Variation and ending 15 months after that date. |\n\nS29—10 Required format for a nutrition information statement\n\n1. The table to this section is:\n\n```html\n

NUTRITION INFORMATION

Average quantity per 100 mL prepared formula

Energy

kJ

Protein

g

— Whey*

g

— Casein*

g

Fat

g

— Long chain polyunsaturated

fatty acids*

— Docosahexaenoic acid (DHA)*

mg

— Eicosapentaenoic acid (EPA)*

mg

— Arachidonic acid (ARA)*

mg

Carbohydrate

g

Vitamins

Vitamin A

μg

Vitamin B6

μg

Vitamin B12

μg

Vitamin C

mg

Vitamin D

μg

Vitamin E

mg

Vitamin K

μg

Biotin

μg

Niacin (B3)

μg

Folate

μg

Pantothenic acid (B5)

μg

Riboflavin (B2)

μg

Thiamin (B1)

μg

Minerals

Calcium

mg

Copper

μg

Iodine

μg

Iron

mg

Magnesium

mg

Manganese

μg

Phosphorus

mg

Selenium

μg

Zinc

mg

Chloride

mg

Potassium

mg

Sodium

mg

Other nutrients*

Choline*

mg

Inositol*

mg

L-carnitine*

mg

Additional

(insert any other substance used as a nutritive substance; or inulin-type fructans and / or galacto-oligosaccharides, to be declared)

g, mg, μg

\n```\n\nNote: \\*See the following.\n\nEntries and amounts for the following need only be included when stated in accordance with subsection 2.9.1—24(4), 2.9.1—24(5) and paragraph 2.9.1—25(6)(d): whey; casein; docosahexaenoic acid; eicosapentaenoic acid; arachidonic acid.\n\nThe heading ‘Other nutrients’ need only be included when required by subparagraph 2.9.1—25(2)(d)(ii) and paragraph 2.9.1—25(4)(a).\n\nThe heading ‘Long chain polyunsaturated fatty acids’ need only be included when required by paragraph 2.9.1—25(6)(a).\n\nEntries and amounts for choline, inositol, L-carnitine are included under the heading ‘Other nutrients’ when required by paragraph 2.9.1—25(4)(a) and under the heading ‘Additional’ when required by paragraph 2.9.1—25(4)(b).\n\nS29—10A Example of a nutrition information statement including quantities expressed as sold\n\n1. For subsection 2.9.1—25(7), an example nutrition information statement including information expressed in accordance with subsection 2.9.1—24(7) is:\n\n```html\n

NUTRITION INFORMATION

Average quantity per 100 mL prepared formula

Quantity per 100 g powder (or 100 mL liquid concentrate)

Energy

kJ

kJ

Protein

g

g

— Whey

g

g

— Casein

g

g

Fat

g

g

— Long chain polyunsaturated

fatty acids

— Docosahexaenoic acid (DHA)

mg

mg

— Eicosapentaenoic acid (EPA)

mg

mg

— Arachidonic acid (ARA)

mg

mg

Carbohydrate

g

g

Vitamins

Vitamin A

μg

μg

Vitamin B6

μg

μg

Vitamin B12

μg

μg

Vitamin C

mg

mg

Vitamin D

μg

μg

Vitamin E

mg

mg

Vitamin K

μg

μg

Biotin

μg

μg

Niacin (B3)

μg

μg

Folate

μg

μg

Pantothenic acid (B5)

μg

μg

Riboflavin (B2)

μg

μg

Thiamin (B1)

μg

μg

Minerals

Calcium

mg

mg

Copper

μg

μg

Iodine

μg

μg

Iron

mg

mg

Magnesium

mg

mg

Manganese

μg

μg

Phosphorus

mg

mg

Selenium

μg

μg

Zinc

mg

mg

Chloride

mg

mg

Potassium

mg

mg

Sodium

mg

mg

Other nutrients

Choline

mg

mg

Inositol

mg

mg

L-carnitine

mg

mg

Additional

(insert any other substance used as a nutritive substance; or inulin-type fructans and / or galacto-oligosaccharides, to be declared)

g, mg, μg

g, mg, μg

\n```\n\nS29—11 Food for infants—claims that can be made about vitamins and minerals added to cereal-based food for infants\n\nFor section 2.9.2—10, the table is:\n\nClaims that can be made about vitamins and minerals added to cereal-based food for infants\n\n| Vitamin or mineral | Maximum claim per serve |\n| ------------------ | ----------------------- |\n| Thiamin (mg) | 15% RDI |\n| Niacin (mg) | 15% RDI |\n| Folate (μg) | 10% RDI |\n| Vitamin B6 (mg) | 10% RDI |\n| Vitamin C (mg) | 10% RDI |\n| Magnesium (mg) | 15% RDI |\n\nS29—12 Formulated meal replacements—vitamins and minerals that must be present in formulated meal replacements\n\n(1) For sections 2.9.3—3, 2.9.3—4 and 2.9.6—4, the table is set out below.\n\n(2) In the table, the amounts set out in columns 2 and 3 are for a 1-meal serving, and are expressed as a proportion of the RDI.\n\nVitamins and minerals that must be present in formulated meal replacements\n\n| Column 1 | Column 2 | Column 3 |\n| ------------------ | -------------- | ------------- |\n| Vitamin or mineral | Maximum amount | Maximum claim |\n| Vitamin A | 300 μg (40%) | 300 μg (40%) |\n| Thiamin | No amount set | 0.55 mg (50%) |\n| Riboflavin | No amount set | 0.85 mg (50%) |\n| Niacin | No amount set | 5 mg (50%) |\n| Folate | No amount set | 100 μg (50%) |\n| Vitamin B6 | No amount set | 0.8 mg (50%) |\n| Vitamin B12 | No amount set | 1 μg (50%) |\n| Vitamin C | No amount set | 20 mg (50%) |\n| Vitamin D | 5.0 μg (50%) | 5 μg (50%) |\n| Vitamin E | No amount set | 5 mg (50%) |\n| Calcium | No amount set | 400 mg (50%) |\n| Iodine | 75 μg (50%) | 75 μg (50%) |\n| Iron | No amount set | 4.8 mg (40%) |\n| Magnesium | No amount set | 160 mg (50%) |\n| Phosphorus | No amount set | 500 mg (50%) |\n| Zinc | No amount set | 4.8 mg (40%) |\n\nS29—13 Vitamins and minerals that may be added to formulated meal replacements\n\n(1) For sections 2.9.3—3, 2.9.3—4 and 2.9.6—4, the table is set out below.\n\n(2) In the table, the amounts set out in columns 2 and 3 are for a 1-meal serving, and are expressed as a proportion of the \\*ESADDI unless stated otherwise.\n\nVitamins and minerals that may be added to formulated meal replacements\n\n| Column 1 | Column 2 | Column 3 |\n| ------------------ | ----------------- | ------------------ |\n| Vitamin or mineral | Maximum amount | Maximum claim |\n| Biotin | No amount set | 5 μg (17%) |\n| Pantothenic acid | No amount set | 0.8 mg (17%) |\n| Vitamin K | No amount set | 40 μg (50%) |\n| Chromium: | | |\n| inorganic | 34 μg (17%) | 34 μg (17%) |\n| organic | 16 μg (8%) | no claim permitted |\n| Copper: | | |\n| inorganic | 0.50 mg (17%) | 0.50 mg (17%) |\n| organic | 0.24 mg (8%) | no claim permitted |\n| Manganese: | | |\n| inorganic | 0.85 mg (17%) | 0.85 mg (17%) |\n| organic | 0.4 mg (8%) | no claim permitted |\n| Molybdenum: | | |\n| inorganic | 42.5 μg (17%) | 42.5 μg (17%) |\n| organic | 20 μg (8%) | no claim permitted |\n| Selenium: | | |\n| inorganic | 17.5 μg (25% RDI) | 17.5 μg (25% RDI) |\n| organic | 9 μg (13% RDI) | 9 μg (13% RDI) |\n\n \n\nS29—14 Vitamins and minerals that may be added to formulated supplementary foods\n\n(1) For sections 2.9.3—5 and 2.9.3—6, the table is set out below.\n\n(2) In the table, the amounts set out in Columns 2 and 3 are for a serving, and are expressed as a proportion of the RDI.\n\nVitamins and minerals that may be added to formulated supplementary foods\n\n| Column 1 | Column 2 | Column 3 |\n| ------------------ | -------------- | ------------- |\n| Vitamin or mineral | Maximum amount | Maximum claim |\n| Vitamins | | |\n| Vitamin A | 340 μg (45%) | 265 μg (35%) |\n| Thiamin | No amount set | 0.55 mg (50%) |\n| Riboflavin | No amount set | 0.85 mg (50%) |\n| Niacin | No amount set | 5 mg (50%) |\n| Folate | No amount set | 100 μg (50%) |\n| Vitamin B6 | No amount set | 0.8 mg (50%) |\n| Vitamin B12 | No amount set | 1 μg (50%) |\n| Vitamin C | No amount set | 20 mg (50%) |\n| Vitamin D | 5 μg (50%) | 5 μg (50%) |\n| Vitamin E | No amount set | 5 mg (50%) |\n| Minerals | | |\n| Calcium | No amount set | 400 mg (50%) |\n| Iodine | 75 μg (50%) | 75 μg (50%) |\n| Iron | No amount set | 6 mg (50%) |\n| Magnesium | No amount set | 130 mg (40%) |\n| Phosphorus | No amount set | 500 mg (50%) |\n| Zinc | No amount set | 3 mg (25%) |\n\nS29—15 Vitamins and minerals that may be added to formulated supplementary food for young children\n\n(1) For sections 2.9.3—7 and 2.9.3—8, the table is set out below.\n\n(2) In the table, the amounts set out in Columns 2 and 3 are for a serving, and are expressed as a proportion of the RDI. \n\nVitamins and minerals that may be added to formulated supplementary food for young children\n\n| Column 1 | Column 2 | Column 3 |\n| ------------------ | ------------------------------------- | ------------------------------------ |\n| Vitamin or mineral | Maximum amount (as percentage of RDI) | Maximum claim (as percentage of RDI) |\n| Vitamins | | |\n| Vitamin A | 135 μg (45%) | 105 μg (35%) |\n| Thiamin | No amount set | 0.25 mg (50%) |\n| Riboflavin | No amount set | 0.4 mg (50%) |\n| Niacin | No amount set | 2.5 mg (50%) |\n| Folate | No amount set | 50 μg (50%) |\n| Vitamin B6 | No amount set | 0.35 mg (50%) |\n| Vitamin B12 | No amount set | 0.5 μg (50%) |\n| Vitamin C | No amount set | 15 mg (50%) |\n| Vitamin D | 2.5 μg (50%) | 2.5 μg (50%) |\n| Vitamin E | No amount set | 2.5 mg (50%) |\n| Minerals | | |\n| Calcium | No amount set | 350 mg (50%) |\n| Iodine | 70 μg (100%) | 35 μg (50%) |\n| Iron | No amount set | 3.0 mg (50%) |\n| Magnesium | No amount set | 32 mg (40%) |\n| Phosphorus | No amount set | 250 mg (50%) |\n| Zinc | No amount set | 1.1 mg (25%) |\n\nS29—16 Vitamins and minerals that may be added to formulated supplementary sports foods\n\n(1) For section 2.9.4—3, the table is set out below.\n\n(2) In the table, the amounts set out in Columns 2 and 3 are for a \\*one-day quantity.\n\nVitamins and minerals that may be added to formulated supplementary sports foods\n\n| Column 1 | Column 2 | Column 3 |\n| ------------------ | -------------- | ------------- |\n| Vitamin or mineral | Maximum amount | Maximum claim |\n| Vitamins | | |\n| Vitamin A | 375 μg | 375 μg |\n| Thiamin | | 2.2 mg |\n| Riboflavin | | 3.4 mg |\n| Niacin | | 20 mg |\n| Folate | | 400 μg |\n| Vitamin B6 | | 3.2 mg |\n| Vitamin B12 | | 4 μg |\n| Vitamin C | | 80 mg |\n| Vitamin D | 2.5 μg | 2.5 μg |\n| Vitamin E | | 20 mg |\n| Biotin | | 50 μg |\n| Pantothenic acid | | 3.5 mg |\n| Minerals | | |\n| Calcium | | 1 600 mg |\n| Chromium: | | |\n| inorganic forms | 100 μg | 100 μg |\n| organic forms | 50 μg | 50 μg |\n| Copper: | | |\n| inorganic forms | 1.5 mg | 1.5 mg |\n| organic forms | 750 μg | 750 μg |\n| Iodine | 75 μg | 75 μg |\n| Iron | | 12 mg |\n| Magnesium | | 640 mg |\n| Manganese: | | |\n| inorganic forms | | 2.5 mg |\n| organic forms | | 1.25 mg |\n| Molybdenum: | | |\n| inorganic forms | | 125 μg |\n| organic forms | | 62.5 μg |\n| Phosphorus | | 1 000 mg |\n| Selenium: | | |\n| inorganic forms | 52 μg | 52 μg |\n| organic forms | 26 μg | 26 μg |\n| Zinc | | 12 mg |\n\nS29—17 Additional permitted forms for vitamins and minerals in formulated supplementary sports foods and in formulated meal replacements\n\nFor sections 2.9.3—3 and 2.9.4—3, the table is:\n\nAdditional permitted forms\n\n| Column 1 | Column 2 |\n| ------------------ | ------------------------------ |\n| Vitamin or mineral | Permitted forms |\n| Biotin | d-biotin |\n| Pantothenic acid | d-sodium pantothenate |\n| Calcium | Calcium hydroxide |\n| Chromium: | |\n| inorganic forms | Chromic chloride |\n| organic forms | High chromium yeast |\n| | Chromium picolinate |\n| | Chromium nicotinate |\n| | Chromium aspartate |\n| Copper: | |\n| inorganic forms | Cupric carbonate |\n| | Cupric sulphate |\n| organic forms | Copper gluconate |\n| | Copper-lysine complex |\n| | Cupric citrate |\n| Magnesium | Magnesium citrate |\n| | Magnesium hydroxide |\n| Manganese: | |\n| inorganic forms | Manganese carbonate |\n| | Manganese chloride |\n| | Manganese sulphate |\n| organic forms | Manganese citrate |\n| Molybdenum: | |\n| inorganic forms | Sodium molybdate |\n| organic forms | High molybdenum yeast |\n| Phosphorus | Magnesium phosphate, monobasic |\n| | Potassium phosphate, tribasic |\n| | Sodium phosphate, monobasic |\n| | Sodium phosphate, tribasic |\n| | Phosphoric acid |\n\nS29—18 Amino acids that may be added to formulated supplementary sports food\n\nFor paragraph 2.9.4—3(1)(b), the table is.\n\nAmino acids that may be added to formulated supplementary sports food\n\n| Column 1 | Column 2 |\n| --------------- | ------------------------------------------------------ |\n| Amino acid | Maximum amount that may be added to a one-day quantity |\n| L-Alanine | 1 200 mg |\n| L-Arginine | 1 100 mg |\n| L-Aspartic acid | 600 mg |\n| L-Cysteine | 440 mg |\n| L-Glutamine | 1 900 mg |\n| L-Glutamic acid | 1 600 mg |\n| Glycine | 1 500 mg |\n| L-Histidine | 420 mg |\n| L-Isoleucine | 350 mg |\n| L-Leucine | 490 mg |\n| L-Lysine | 420 mg |\n| L-Methionine | 180 mg |\n| L-Ornithine | 360 mg |\n| L-Phenylalanine | 490 mg |\n| L-Proline | 1 100 mg |\n| L-Serine | 1 400 mg |\n| L-Taurine | 60 mg |\n| L-Threonine | 245 mg |\n| L-Tyrosine | 400 mg |\n| L-Tryptophan | 100 mg |\n| L-Valine | 350 mg |\n\nS29—19 Substances that may be used as nutritive substances in formulated supplementary sports food\n\nFor paragraph 2.9.4—3(1)(c), the table is:\n\nSubstances that may be used as nutritive substances in formulated supplementary sports food\n\n| Column 1 | Column 2 |\n| -------------- | ------------------------------------------------------ |\n| Substance | Maximum amount that may be added to a one-day quantity |\n| L-carnitine | 2g |\n| Choline | 10 mg |\n| Inosine | 10 mg |\n| Ubiquinones | 15 mg |\n| Creatine | 3 g |\n| Gamma-oryzinol | 25 mg |\n\nS29—20 Substances that may be added to food for special medical purposes\n\nFor section 2.9.5—6, the table is.\n\nSubstances that may be added to food for special medical purposes\n\n| Column 1 | Column 2 |\n| ------------------------- | ---------------------------------------------------------------------------------------- |\n| Substance | Permitted forms |\n| Vitamins | |\n| Niacin | Nicotinamide riboside chloride |\n| | Nicotinic acid |\n| Vitamin B6 | Pyridoxine dipalmitate |\n| Folate | Calcium L-methylfolate |\n| Vitamin E | D-alpha-tocopherol |\n| | D-alpha-tocopheryl polyethylene glycol-1000 succinate (TPGS) |\n| Vitamin K | Vitamin K2 (as menaquinone-7) |\n| Pantothenic acid | Sodium pantothenate |\n| | D-panthenol |\n| | DL-panthenol |\n| Minerals and electrolytes | |\n| Boron | Sodium borate |\n| | Boric acid |\n| Calcium | Calcium bisglycinate |\n| | Calcium citrate malate |\n| | Calcium malate |\n| | Calcium L-pidolate |\n| Chloride | Choline chloride |\n| | Sodium chloride, iodised |\n| | Hydrochloric acid |\n| Chromium | Chromium chloride |\n| | Chromium picolinate |\n| | Chromium potassium sulphate |\n| Copper | Copper-lysine complex |\n| | Cupric carbonate |\n| Fluoride | Potassium fluoride |\n| | Sodium fluoride |\n| Iodine | Sodium iodate |\n| Iron | Carbonyl iron |\n| | Electrolytic iron |\n| | Ferric citrate |\n| | Ferric gluconate |\n| | Ferric orthophosphate |\n| | Ferric pyrophosphate, sodium |\n| | Ferric saccharate |\n| | Ferric sodium diphosphate |\n| | Ferrous bisglycinate |\n| | Ferrous carbonate |\n| | Ferrous carbonate, stabilised |\n| | Ferrous L-pidolate |\n| | Iron, reduced (ferrum reductum) |\n| Magnesium | Magnesium acetate |\n| | Magnesium L-aspartate |\n| | Magnesium bisglycinate |\n| | Magnesium citrate |\n| | Magnesium glycerophosphate |\n| | Magnesium hydroxide |\n| | Magnesium hydroxide carbonate |\n| | Magnesium lactate |\n| | Magnesium phosphate, monobasic |\n| | Magnesium L-pidolate |\n| | Magnesium potassium citrate |\n| Manganese | Manganese glycerophosphate |\n| Molybdenum | Ammonium molybdate |\n| Potassium | Potassium glycerophosphate |\n| | Potassium lactate |\n| | Potassium L-pidolate |\n| Selenium | Selenium enriched yeast |\n| | Sodium hydrogen selenite |\n| | Sodium selenate |\n| Zinc | Zinc bisglycinate |\n| | Zinc carbonate |\n| | Zinc citrate |\n| | Zinc lactate |\n| Other substances | |\n| Amino acids | Sodium, potassium, calcium, magnesium salts of single amino acids listed in this section |\n| | Hydrochlorides of single amino acids listed in this section |\n| | L-alanine |\n| | L-arginine |\n| | L-arginine acetate |\n| | L-asparagine |\n| | L-aspartic acid |\n| | L-citrulline |\n| | L-cysteine |\n| | L-cystine |\n| | L-glutamic acid |\n| | L-glutamine |\n| | Glycine |\n| | L-histidine |\n| | L-isoleucine |\n| | L-leucine |\n| | L-lysine |\n| | L-lysine acetate |\n| | L-methionine |\n| | L-ornithine |\n| | L-phenylalanine |\n| | L-proline |\n| | L-serine |\n| | L-threonine |\n| | L-tyrosine |\n| | L-tryptophan |\n| | L-valine |\n| | L-arginine-L-aspartate |\n| | L-lysine-L-aspartate |\n| | L-lysine-L-glutamate |\n| | N-acetyl-L-methionine |\n| Carnitine | L-carnitine |\n| | L-carnitine hydrochloride |\n| | L-carnitine L-tartrate |\n| Choline | Choline |\n| | Choline bitartrate |\n| | Choline chloride |\n| | Choline citrate |\n| | Choline hydrogen tartrate |\n| Inositol | Inositol |\n| Nucleotides | Adenosine-5′-monophosphate |\n| | Adenosine-5′-monophosphate sodium salt |\n| | Cytidine-5′-monophosphate |\n| | Cytidine-5′-monophosphate sodium salt |\n| | Guanosine-5′-monophosphate |\n| | Guanosine-5′-monophosphate sodium salt |\n| | Inosine-5′-monophosphate |\n| | Inosine-5′-monophosphate sodium salt |\n| | Uridine-5′-monophosphate |\n| | Uridine-5′-monophosphate sodium salt |\n| Taurine | Taurine |\n\nS29—21 Amounts of nutrients for food for special medical purposes represented as a sole source of nutrition\n\nFor section, 2.9.5—7, the table is:\n\nAmounts of nutrients for food for special medical purposes represented as a sole source of nutrition\n\n| Column 1 | Column 2 | Column 3 |\n| ------------------------------------------------------- | ---------------------------------- | --------------------------- |\n| Nutrient | Minimum amount per MJ | Maximum amount per MJ |\n| Vitamins | | |\n| Vitamin A | 84 µg retinol equivalents1 | 430 µg retinol equivalents1 |\n| Thiamin | 0.15 mg | No maximum set |\n| Riboflavin | 0.2 mg | No maximum set |\n| Niacin | 2.2 mg niacin equivalents2 | No maximum set |\n| Vitamin B6 | 0.2 mg | 1.2 mg |\n| Folate | 25 µg | No maximum set |\n| Vitamin B12 | 0.17 µg | No maximum set |\n| Vitamin C | 5.4 mg | No maximum set |\n| Vitamin D | | |\n| (a) for products intended for children aged 1–10 years— | 1.2 µg | 7.5 µg |\n| (b) otherwise— | 1.2 µg | 6.5 µg |\n| Vitamin E | 1 mg alpha-tocopherol equivalents3 | No maximum set |\n| Biotin | 1.8 µg | No maximum set |\n| Pantothenic Acid | 0.35 mg | No maximum set |\n| Vitamin K | 8.5 µg | No maximum set |\n| Minerals | | |\n| Calcium | | |\n| (a) for products intended for children aged 1–10 years— | 120 mg | 600 mg |\n| (b) otherwise— | 84 mg | 420 mg |\n| Magnesium | 18 mg | No maximum set |\n| Iron | 1.2 mg | No maximum set |\n| Phosphorus | 72 mg | No maximum set |\n| Zinc | 1.2 mg | 3.6 mg |\n| Manganese | 0.12 mg | 1.2 mg |\n| Copper | 0.15 mg | 1.25 mg |\n| Iodine | 15.5 µg | 84 µg |\n| Chromium | 3 µg | No maximum set |\n| Molybdenum | 7 µg | No maximum set |\n| Selenium | 6 µg | 25 µg |\n| Electrolytes | | |\n| Sodium | 72 mg | No maximum set |\n| Potassium | 190 mg | No maximum set |\n| Chloride | 72 mg | No maximum set |\n\nNote 1 See paragraph 1.1.2—14(3)(a).\n\nNote 2 For niacin, add niacin and any niacin provided from the conversion of the amino acid tryptophan, using the conversion factor 1:60.\n\nNote 3 See paragraph 1.1.2—14(3)(c). \n\nS29—22 Nutritional content requirements for a very low energy diet\n\nFor paragraph 2.9.5—18(1)(f), the table is:\n\nAmounts of nutrients in a very low energy diet\n\n| Column 1 | Column 2 |\n| ------------------------------------ | ------------------------------- |\n| Nutrient | Minimum amount per daily intake |\n| Vitamins | |\n| Vitamin A | 600 µg retinol equivalents1 |\n| Vitamin D | 2.5 µg |\n| Vitamin E | 10 mg α-tocopherol equivalents2 |\n| Vitamin C | 30 mg |\n| Vitamin B6 | 2 mg |\n| Vitamin B12 | 1 µg |\n| Niacin | 11 mg niacin equivalents3 |\n| Riboflavin | 1.2 mg |\n| Thiamin | 0.8 mg |\n| Folic Acid | 200 µg |\n| Minerals | |\n| CalciumPhosphorusIronIodineMagnesium | 500 mg500 mg16 mg140 µg350 mg |\n| CopperZincPotassiumSodium | 1.5 mg6 mg1.6 g1 g |\n\nNote 1 See paragraph 1.1.2—14(3)(a).\n\nNote 2 See paragraph 1.1.2—14(3)(c).\n\nNote 3 For niacin, add niacin and any niacin provided from the conversion of the amino acid tryptophan, using the conversion factor 1:60.\n\nS29—23 Permitted forms of vitamins, minerals and electrolytes in infant formula products, food for infants, formulated meal replacements (vitamin K) and food for special medical purposes\n\nFor sections 2.9.1—10(a), 2.9.1—38(a), 2.9.2—4, 2.9.2—5, 2.9.2—6, 2.9.3—3(2)(c)(iii) and 2.9.5—6, the table is:\n\nPermitted forms of vitamins, minerals and electrolytes in infant formula products, food for infants, formulated meal replacements (vitamin K) and food for special medical purposes\n\n| Vitamin, mineral or electrolyte | Permitted forms |\n| ------------------------------- | ---------------------------------------------------------------- |\n| Vitamin A | |\n| Retinol forms | vitamin A (retinol) |\n| | vitamin A acetate (retinyl acetate) |\n| | vitamin A palmitate (retinyl palmitate) |\n| | retinyl propionate |\n| Provitamin A forms | beta-carotene |\n| Vitamin C | L-ascorbic acid |\n| | L-ascorbyl palmitate |\n| | calcium ascorbate |\n| | potassium ascorbate |\n| | sodium ascorbate |\n| Vitamin D | vitamin D2 (ergocalciferol) |\n| | vitamin D3 (cholecalciferol) |\n| | vitamin D (cholecalciferol-cholesterol) |\n| Thiamin | thiamin hydrochloride |\n| | thiamin mononitrate |\n| Riboflavin | riboflavin |\n| | riboflavin-5′-phosphate, sodium |\n| Niacin | niacinamide (nicotinamide) |\n| Vitamin B6 | pyridoxine hydrochloride |\n| | pyridoxine-5′-phosphate |\n| Folate | Folic acid |\n| Pantothenic acid | calcium pantothenate |\n| | dexpanthenol |\n| | D-panthenol |\n| | calcium D-pantothenate |\n| | sodium D-pantothenate |\n| Vitamin B12 | cyanocobalamin |\n| | hydroxocobalamin |\n| Biotin | d-biotin |\n| Vitamin E | dl-α-tocopherol |\n| | d-α-tocopherol concentrate |\n| | tocopherols concentrate, mixed |\n| | d-α-tocopheryl acetate |\n| | dl-α-tocopheryl acetate |\n| | d-α-tocopheryl acid succinate |\n| | dl-α-tocopheryl succinate |\n| Vitamin K | Vitamin K1 as phylloquinone (phytonadione) |\n| Calcium | calcium carbonate |\n| | calcium chloride |\n| | calcium citrate |\n| | calcium gluconate |\n| | calcium glycerophosphate |\n| | calcium hydroxide |\n| | calcium lactate |\n| | calcium oxide |\n| | calcium phosphate, dibasic |\n| | calcium phosphate, monobasic |\n| | calcium phosphate, tribasic |\n| | calcium sulphate |\n| Chloride | calcium chloride |\n| | magnesium chloride |\n| | potassium chloride |\n| | sodium chloride |\n| Chromium | chromium sulphate |\n| Copper | copper gluconate |\n| | cupric sulphate |\n| | cupric citrate |\n| | cupric carbonate |\n| Iodine | potassium iodate |\n| | potassium iodide |\n| | sodium iodide |\n| Iron | ferric ammonium citrate |\n| | ferric citrate |\n| | ferric pyrophosphate |\n| | ferrous bisglycinate |\n| | ferrous citrate |\n| | ferrous fumarate |\n| | ferrous gluconate |\n| | ferrous lactate |\n| | ferrous succinate |\n| | ferrous sulphate |\n| Magnesium | magnesium carbonate |\n| | magnesium chloride |\n| | magnesium gluconate |\n| | magnesium oxide |\n| | magnesium phosphate, dibasic |\n| | magnesium phosphate, tribasic |\n| | magnesium sulphate |\n| | magnesium hydroxide carbonate |\n| | magnesium hydroxide |\n| | magnesium salts of citric acid |\n| Manganese | manganese carbonate |\n| | manganese chloride |\n| | manganese citrate |\n| | manganese gluconate |\n| | manganese sulphate |\n| Molybdenum | sodium molybdate VI |\n| Phosphorus | calcium glycerophosphate |\n| | calcium phosphate, dibasic |\n| | calcium phosphate, monobasic |\n| | calcium phosphate, tribasic |\n| | magnesium phosphate, dibasic |\n| | potassium phosphate, dibasic |\n| | potassium phosphate, monobasic |\n| | potassium phosphate, tribasic |\n| | sodium phosphate, dibasic |\n| | sodium phosphate, monobasic |\n| | sodium phosphate, tribasic |\n| Potassium | potassium bicarbonate |\n| | potassium carbonate |\n| | potassium chloride |\n| | potassium citrate |\n| | potassium glycerophosphate |\n| | potassium gluconate |\n| | potassium hydroxide |\n| | potassium phosphate, dibasic |\n| | potassium phosphate, monobasic |\n| | potassium phosphate, tribasic |\n| | potassium L-lactate |\n| Selenium | seleno methionine |\n| | sodium selenate |\n| | sodium selenite |\n| Sodium | sodium bicarbonate |\n| | sodium carbonate |\n| | sodium chloride |\n| | sodium chloride iodised |\n| | sodium citrate |\n| | sodium gluconate |\n| | sodium hydroxide |\n| | sodium iodide |\n| | sodium lactate |\n| | sodium phosphate, dibasic |\n| | sodium phosphate, monobasic |\n| | sodium phosphate, tribasic |\n| | sodium sulphate |\n| | sodium tartrate |\n| Zinc | zinc acetate |\n| | zinc chloride |\n| | zinc citrate (zinc citrate dihydrate or zinc citrate trihydrate) |\n| | zinc gluconate |\n| | zinc lactate |\n| | zinc oxide |\n| | zinc sulphate |\n\n \n\nApplication, saving and transitional provisions\n\nThe table below details information on application, saving or transitional provisions in instruments affecting this Standard.\n\n```html\n

Instrument items affected

A’ment No.

FRLI registration

Gazette

Instrument’s transitional provision

Description of transitional arrangement

Food Standards (Application A1230 – Very Low Energy Diets (VLED)) Variation

Item [4.1] of the Schedule

208

F2022L00733

1 June 2022

FSC 148

1 June 2022

Clause 4

Clause 4 of the Food Standards (Application A1230 – Very Low Energy Diets (VLED)) Variation provides a transitional arrangement for the variations to the Code made by Item [4.1] of the Schedule to that legislative instrument.

Subclause 4(1) provides that section 1.1.1—9 of the Code does not apply to the variations made by that instrument.

Subclause 4(2) provides that, during the transition period, a food product may be sold if the product complies with one of the following:

  1. the Code as in force without the variations made by the instrument;
  2. the Code as amended by the variations made by the instrument.

Subclause 4(3) provides that, for the purposes of the above, the transition period is the period commencing on the variation’s date of commencement and ending 36 months after the date of commencement.

This means that the transition period is the period of time that commences on 1 June 2022 and ends on 1 June 2025.

Food Standards (Proposal P1028 – Infant Formula Products – Consequential Amendments) Variation

Items [1] and [2] of Schedule 1

231

F2024L01151

13 Sept 2024

FSC 171

13 Sept 2024

Clause 4

Clause 4 establishes a transitional arrangement for variations to the Code made by Items [1] and [2] of Schedule 1 and by the Food Standards (Proposal P1028 – Infant Formula Products – Consequential Amendments) Variation.

The transition period is the period of time that commences on 13 September 2024 and ends on 13 September 2029.

Subclause 4(1) provides that section 1.1.1—9 of the Code does not apply to the variations.

Subclause 4(2) provides that during the transition period a food product may be sold if the product complies with one of the following:

(a) the Code as in force without the above variations;

(b) the Code as amended by the above variations.

Subclause 4(3) provides that a food product that was labelled before the end of the transition period may be sold after the transition period if the product complies with one of the following:

(a) the Code as in force without the above variations;

(b) the Code as amended by the above variations.

\n```\n\nAmendment History\n\nThe Amendment History provides information about each amendment to the Schedule. The information includes commencement or cessation information for relevant amendments.\n\nThese amendments are made under section 92 of the Food Standards Australia New Zealand Act 1991 unless otherwise indicated. Amendments do not have a specific date for cessation unless indicated as such.\n\nAbout this compilation\n\nThis is compilation No. 17 of Schedule 29 as in force on 20 January 2026 (up to Amendment No. 247). It includes any commenced amendment affecting the compilation to that date.\n\nPrepared by Food Standards Australia New Zealand on 20 January 2026.\n\nUncommenced amendments or provisions ceasing to have effect.\n\nTo assist stakeholders, the effect of any uncommenced amendments or provisions which will cease to have effect, may be reflected in the Schedule as shaded boxed text with the relevant commencement or cessation date. These amendments will be reflected in a compilation registered on the Federal Register of Legislation including or omitting those amendments and provided in the Amendment History once the date is passed.\n\nThe following abbreviations may be used in the table below:\n\nad = added or inserted am = amended\n\nexp = expired or ceased to have effect rep = repealed\n\nrs = repealed and substituted\n\nSchedule 29 was published in the Food Standards Gazette No. FSC96 on 10 April 2015 as part of Amendment 154 (F2015L00463 –- 1 April 2015) and has since been amended as follows:\n\n| Section affected | A’ment No. | FRL registrationGazette | Commencement(Cessation) | How affected | Description of amendment |\n| ----------------------- | ---------- | -------------------------------------------------------------------------------------- | ----------------------- | ------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| S29—7 | 172 | F2017L011426 Sept 2017FSC1147 Sept 2017 | 7 Sept 2017 | am | Omit ‘phytylmenoquinone’ from table. |\n| S29—10(3) | 157 | F2015L013741 Sept 2015FSC993 Sept 2015 | 1 March 2016 | rs | Subsection and related table. |\n| S29—17 | 161 | F2016L0012018 Feb 2016FSC10322 Feb 2016 | 1 March 2016 | am | Correction of typographical error in table heading. |\n| S29—20 | 168 | F2017L0041411 April 2017FSC11013 April 2017 | 13 April 2017 | am | Insertion of a sodium fluoride as a permitted form of fluoride which was inadvertently omitted in FSC96. |\n| S29—20 | 173 | F2017L0117613 Sept 2017FSANZ Notification Circular 24-17 (Urgent Proposal)14 Sept 2017 | 14 Sept 2017 | am | Omit L-arginine and substituting L-arginine and L-arginine acetate as a permitted form of Amino acids. |\n| S29—21 | 161 | F2016L0012018 Feb 2016FSC10322 Feb 2016 | 1 March 2016 | rs | Notes 1, 2 and 3 to correct incorrect cross-reference and missing full stops. |\n| S29—21 | 168 | F2017L0041411 April 2017FSC11013 April 2017 | 13 April 2017 | am | Correction to abbreviation of megajoule in the heading,Correction to formatting error for entry for vitamin E. |\n| S29—14 | 182 | F2018L0159423 Nov 2018FSC12329 Nov 2018 | 29 Nov 2018 | am | Corrections to typographical error (1) |\n| S29—14 | 186 | F2019L0099617 July 2019FSC12725 July 2019 | 25 July 2019 | am | Omit L-carnitine 100mg and substitute L‑carnitine 2g |\n| S29—5 | 198 | F2021L0033225 March 2021FSC13926 March 2021 | 26 March 2021 | am | Inserting 2′-O-fucosyllactose and lacto-N-neotetraose |\n| S29—7 | 200 | F2021L006842 June 2021FSC1413 June 2021 | 3 June 2021 | am | Correction of typographical error in table heading. |\n| S29—20 | 203 | F2021L0143114 October 2021FSC14421 October 2021 | 21 October 2021 | am | Omit nicotinic acid and substitute Nicotinamide riboside chloride and nicotinic acid |\n| 2.9.1—5 | 205 | F2022L0003818 Jan 2022FSC14620 Jan 2022 | 20 January 2022 | rs | Omit 2′-O-fucosyllactose and substitute 2′-fucosyllactose |\n| S29—22 | 208 | F2022L007331 June 2022FSC 1481 June 2022 | 1 June 2022 | ad | Added section 22For application, saving and transitional provisions, see above table. |\n| S29—5 | 217 | F2023L0045219 April 2023FSC15721 April 2023 | 21 April 2023 | ad | Insert entry for lactoferrin – bovine lactoferrin. |\n| S29—5A | 217 | F2023L0045219 April 2023FSC15721 April 2023 | 21 April 2023 | ad | Insert section S29—5A |\n| S29—5 | 223 | F2023L0156127 Nov 2023FSC16330 Nov 2023 | 30 Nov 2023 | ad | Insert in table to S29—5 entries for the following substances:3'-sialyllactose sodium salt,6'-sialyllactose sodium salt,a combination of 2′-fucosyllactose with difucosyllactose, andlacto-N-tetraose |\n| S29—2 through to S29—10 | 231 | F2024L0115113 Sept 2024FSC17113 Sept 2024 | 13 Sept 2024 | rs | Repeal sections S29—2 to S29—10 and substitute with new S29—2 to S29—10A |\n| S29—23 | 231 | F2024L0115113 Sept 2024FSC17113 Sept 2024 | 13 Sept 2024 | ad | Insert after section s29—22 new section entry S29—23 |\n| S29—20 | 235 | F2025L0016320 Feb 2025FSC 17520 Feb 2025 | 20 February 2025 | ad | Insert new entry for vitamin K |\n| S29—7 through to S29-9A | 240 | F2025L0085722 July 2025FSC 18022 July 2025 | 22 July 2025 | ad | Insert to tables S29—7, S29—8, S29—9 and S29—9A new entry for milk fat globule membrane-enriched whey protein concentrate |\n| S29—7, S29—8 & S29—9 | 247 | F2026L0002215 January 2026FSC 18720 January 2026 | 20 January 2026 | am | Insert to tables new entry for 3-fucosyllactose permitted for use by Standard 1.5.2 |","sortOrder":0}],"analysis":{"summary":{"content_quality":"ok","complexity_score":4,"scope_assessment":{"changed":false,"description":"This schedule is a permanent part of the Australia New Zealand Food Standards Code, setting ongoing requirements for special purpose foods. It is not a standalone narrow instrument but a standing technical standard, though it has been amended from time to time."},"complexity_factors":["Dense numerical tables with precise nutrient limits per 100 kJ or per serving","Extensive cross-references to multiple other standards and subsections of the Code","Highly technical terminology and units (µg RE, α-TE, nitrogen-to-protein conversion factors)","Mix of mandatory, optional and guidance-level nutrients with detailed conditions of use","Transitional provisions with specific commencement and end dates for recent amendments"],"plain_english_summary":"Schedule 29 to the Australia New Zealand Food Standards Code is the technical rulebook that fixes mandatory nutrient composition, permitted ingredients and the required nutrition‑label layout for special purpose foods (infant and follow‑on formula, meal replacements, supplementary foods, sports foods, foods for special medical purposes and very low energy diets). \n\nWho it affects: manufacturers, importers, packers, retailers and regulators in Australia and New Zealand — noncompliant products can’t be sold. Recent amendments include transitional sell‑through periods (to June 2025 and September 2029)."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"kimi_summary":{"_metrics":{"completionTokens":679},"content_quality":"ok","complexity_score":8,"scope_assessment":{"changed":false,"description":"This Schedule appears to maintain its original scope as a technical schedule providing detailed compositional and labelling requirements for special purpose foods. While it has been extensively amended over time (17 compilations to date), these amendments have added new nutrients, updated scientific requirements, and refined labelling formats rather than expanding beyond the original purpose of regulating infant formula, medical foods, and related products."},"complexity_factors":["Extensive cross-referencing to other Standards (2.9.1, 2.9.2, 2.9.3, 2.9.4, 2.9.5, 2.9.6, 1.5.2, 1.1.1, S11—2)","Multiple measurement units (μg, mg, g, kJ, MJ, percentages of RDI/ESADDI)","Numerous conditional provisions (e.g. 'if required by paragraph X', 'need only be included when')","Complex tables with 4+ columns specifying minimums, maximums, guidance upper levels, and permitted forms","Brand-specific exclusive use periods for certain ingredients (e.g. Synlait lactoferrin, Lacprodan MFGM-10)","Dual jurisdiction application with different legislative frameworks in Australia and New Zealand","Extensive amendment history with transitional provisions and uncommenced amendments","Scientific terminology requiring specialised knowledge (e.g. specific chemical forms of nutrients, amino acid salts)","Nested definitions and conversion factors (e.g. nitrogen-to-protein conversion factor of 6.25, niacin equivalents calculation)","Multiple categories of products with subtly different requirements (infant formula vs follow-on formula vs special medical purpose foods)"],"plain_english_summary":"This Schedule sets out the detailed technical requirements for **special purpose foods** in Australia and New Zealand — primarily products for infants, people with medical conditions, and those needing controlled nutrition.\n\n**What it covers:**\n\n- **Infant formula products** — rules for calculating energy, protein and vitamin A content; mandatory minimum amounts of 11 specific amino acids; limits on fatty acids like DHA and trans fats; required and optional vitamins, minerals and other nutrients\n\n- **Follow-on formula** — nutritional requirements for older infants\n\n- **Food for infants** — vitamin and mineral claims allowed on cereal-based foods\n\n- **Formulated meal replacements** — products used for weight management, with required and permitted vitamins/minerals and maximum claim levels\n\n- **Formulated supplementary foods** — including versions for young children and sports foods, with detailed nutrient limits and permitted amino acids\n\n- **Food for special medical purposes** — extensive rules for products used as sole nutrition or very low energy diets, including permitted forms of vitamins, minerals, amino acids and other substances\n\n- **Labelling** — required nutrition information statement formats for infant formula products\n\n**Who it affects:** Food manufacturers, importers, retailers, healthcare professionals, and consumers — particularly parents of infants and people with special dietary needs.\n\n**Why it matters:** These rules ensure special purpose foods are safe, nutritionally adequate, and properly labelled. The standards are legally enforceable and apply across both Australia and New Zealand."},"flash_summary":{"complexity_score":8,"scope_assessment":{"changed":true,"description":"The Schedule has expanded beyond simple nutrient limits and labelling templates to incorporate approvals for novel nutritive substances (eg HMOs, lactoferrin, milk fat globule membrane concentrates) and to specify permitted chemical forms and short branded exclusive‑use periods for particular supplier products (see S29—7, S29—9, S29—9A). These additions broaden the instrument from a prescriptive nutrient and label standard into a mechanism that also governs market access for specific ingredients and suppliers. The transitional provisions and repeated amendments (Amendment History) further extend operational scope by permitting parallel compliance regimes for set transition periods (Application, saving and transitional provisions)."},"complexity_factors":["23 separate sections (S29—1 to S29—23) with multiple large tables","Extensive numeric specifications: dozens of minimum, maximum and guidance upper levels across many nutrients","Numerous cross‑references to other parts of the Food Standards Code (e.g. Standard 2.9.1, Standard 1.5.2, S11—2 and calculation rules)","Conditional entries and optional headings that are only required in particular circumstances (see notes to S29—10 and S29—10A)","Multiple permitted chemical forms for each vitamin/mineral (S29—23) increasing interpretive complexity","Novel ingredient approvals with time‑limited exclusive‑use conditions (S29—9A) introduce temporal complexity","Transitional and saving provisions with multiple overlapping transition periods and amendment history (detailed table and notes)","Nested exceptions and guidance upper levels that are recommended (not absolute) and have specific exceptions (e.g. technological reasons or high/variable contents)","Frequent amendments and insertions in the Amendment History requiring attention to version/date (many A’ment numbers and commencement dates)","Different measurement bases and conversion rules to apply depending on product category (per MJ, per 100 kJ, per serving, per 1‑meal serving, per one‑day quantity etc.)"],"plain_english_summary":"**What this instrument does (mechanics)\n\n- Sets detailed compositional and labelling rules for \"special purpose foods\" (infant formula, follow‑on formula, food for infants, formulated meal replacements, formulated supplementary foods, formulated supplementary sports foods, very low energy diets and foods for special medical purposes). See S29—2 to S29—23.\n- Prescribes exactly how certain values must be calculated and expressed (for example energy in infant formula is calculated from fat, protein and carbohydrate using energy factors in S11—2 and expressed in kilojoules — S29—2; protein is calculated from nitrogen using a 6.25 conversion factor — S29—2A).\n- Lists required minimums, maximums and recommended upper guidance levels for many vitamins, minerals, amino acids, fatty acids, electrolytes and other nutritive substances across different product categories (multiple tables: S29—3, S29—4, S29—5, S29—6, S29—12 to S29—16, S29—21, S29—22).\n- Lists optional nutritive substances and permissible amounts and forms for infant formulas, follow‑on formulas and follow‑on foods (S29—7, S29—8, S29—9, S29—9A). This includes human milk oligosaccharides (HMOs) such as 2'-fucosyllactose and 3‑fucosyllactose, lactoferrin, milk fat globule membrane concentrates, sialyllactoses, and others (see S29—7, S29—8 and amendment history).\n- Specifies the exact layout and content required for nutrition information statements on infant formula labels and gives an example including quantities as sold (S29—10 and S29—10A).\n- Sets permitted chemical/technical forms for vitamins, minerals and electrolytes used in specified products (S29—23 and other cross‑references).\n- Contains conditions that can be placed on permitted nutritive substances — for example short exclusive‑use periods tied to a brand name for particular supplier products (S29—9A).\n- Provides transitional and application arrangements for amendments (see the Application, saving and transitional provisions table and Amendment History).\n\nWho is affected\n\n- Food manufacturers and ingredient suppliers that formulate, import, label or sell the categories of special purpose foods covered (infant formula and follow‑on formula manufacturers are the most heavily regulated by this Schedule).\n- Retailers and distributors who sell those products, because labelling and composition changes affect what they may stock and sell during transitional periods.\n- Ingredient innovators and suppliers (manufacturers of HMOs, lactoferrin, MFGM concentrates, etc.), because the instrument controls whether and how their products may be used in regulated foods (see S29—7, S29—9 and S29—9A).\n- Testing laboratories and compliance authorities, because enforcement requires laboratory verification of nutrient contents and forms.\n\nWhy it matters (official purpose and practical effects)\n\n- The stated purpose is to protect infant and consumer nutrition and safety by prescribing minimum and maximum nutrient levels, permitted nutrient forms, and label formats so that products are nutritionally appropriate and consistently declared (see S29—5, S29—6, S29—10, S29—23).\n- Mechanically, the Schedule determines:\n - What nutrients must or may be present, and in which amounts (affects formulation and sourcing) (e.g. S29—5, S29—6, S29—12).\n - Which chemical forms of vitamins/minerals are acceptable (affects ingredient selection and supplier compatibility) (S29—23).\n - How information must appear on labels (affects packaging design and printing runs) (S29—10).\n - Whether a novel nutritive substance may be used and under what conditions, including temporary exclusive‑use conditions for particular branded ingredients (S29—9A).\n\nImplementation costs, incentives and trade‑offs (practical testing of the official rationale)\n\n- Who pays: primarily manufacturers and ingredient suppliers. Costs include reformulation, additional testing, new supplier contracts, label redesign, and potential product recall or discontinuation if out of compliance. Regulators incur enforcement and guidance costs.\n- Incentives and concentrated benefits: the Schedule creates demand for permitted, approved forms of novel ingredients (benefit to producers of those ingredients). Where the Schedule contains an \"exclusive use\" condition (S29—9A), that creates a short period during which a specified supplier and brand have sole permitted use of an ingredient in infant formula — a concentrated commercial benefit to that supplier during the exclusive period, while manufacturers seeking that ingredient must source it from the specified brand or wait until exclusivity ends.\n- Trade‑offs and opportunity costs: specifying permitted forms and tight numeric ranges can improve consistency and safety but reduces formulators’ flexibility to use alternative raw materials or processes. Strict labelling and calculation rules (eg S29—2, S29—2A) increase compliance certainty but raise compliance costs.\n- Compliance burden and implementation risk: extensive tables and cross‑references (S29—2 to S29—23 plus references to other Parts of the Code) increase the risk of misinterpretation by manufacturers and enforcement bodies. Novel ingredient approvals with conditions (S29—9A) require administrative tracking (gazettal dates, exclusive periods). Transitional provisions add temporary dual‑compliance regimes that industry must manage (see Application, saving and transitional provisions).\n- Effects on private choice and competition: the Schedule narrows technical choices for product formulators (permitted forms and max/min amounts). Where a short exclusive use period is imposed, supply concentration and short‑term market power for the named supplier are introduced (S29—9A). Otherwise, the Schedule opens the market to specific novel ingredients once permitted, potentially increasing product differentiation.\n\nClear behavioural changes required\n\n- Manufacturers must ensure formulations meet the listed nutrient minima/maxima and use only permitted chemical forms (e.g. S29—5, S29—6, S29—23).\n- Labels must adopt the prescribed nutrition information statement format and include specified entries when required (S29—10, S29—10A).\n- Ingredient sourcing decisions will shift toward suppliers of permitted substances and permitted forms; in cases of exclusive‑use conditions manufacturers must source the branded supply if they wish to use the ingredient during the exclusive window (S29—9A).\n\nKey sections to note for commercial or compliance decisions\n\n- Calculation and expression of energy and protein: S29—2, S29—2A.\n- Mandatory nutrient minima/maxima and Guidance Upper Levels for infants and follow‑on formulas: S29—5, S29—6.\n- Optional but permitted novel nutritive substances and maxima: S29—7, S29—8.\n- Permitted forms and specific technical conditions for use (including branded exclusive periods): S29—9, S29—9A, S29—23.\n- Required format and examples for nutrition information statements and how to report quantities as sold: S29—10, S29—10A.\n- Transitional arrangements and amendment history (affecting when rules apply and labelling stock that was produced earlier): Application, saving and transitional provisions table and Amendment History.\n\nConcise takeaway\n\nThis Schedule turns high‑level nutrition policy into precise technical and labelling rules. It fixes how manufacturers must calculate and declare nutrient contents, lists permissible nutrients and forms for each special purpose food category, and sets some short supplier‑specific conditions for novel ingredients. The direct costs fall on manufacturers and ingredient suppliers (testing, reformulation, labelling), while the Schedule also shifts sourcing and competitive dynamics where it approves new ingredients or grants short exclusive supplier windows (see S29—5, S29—7, S29—9A)."}},"importantCases":[],"_links":{"self":"/api/acts/australia-new-zealand-food-standards-code-schedule-29-special-purpose-foods","history":"/api/acts/australia-new-zealand-food-standards-code-schedule-29-special-purpose-foods/history","analysis":"/api/acts/australia-new-zealand-food-standards-code-schedule-29-special-purpose-foods/analysis","conflicts":"/api/acts/australia-new-zealand-food-standards-code-schedule-29-special-purpose-foods/conflicts","importantCases":"/api/acts/australia-new-zealand-food-standards-code-schedule-29-special-purpose-foods/important-cases","documents":"/api/acts/australia-new-zealand-food-standards-code-schedule-29-special-purpose-foods/documents"}}